Publications by authors named "Heba Ewida"

Claim this Profile
D
Discovery of pan-EphB tyrosine kinase inhibitor for metabolic syndrome sparing EphB3 signaling in mice.
Syed Tareq, Heba A Ewida, Sumaih Zoubi, Harrison Benson, Dhavalkumar Patel

Pharmacol Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose acetaminophen does not acutely compromise blood-brain barrier permeability in mice.
Sumaih Zoubi, Dhavalkumar Patel, Yeseul Ahn, Ehsan Nozohouri, Heba Ewida

Metab Brain Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Targets and Small Molecules Modulating Acetyl Coenzyme A in Physiology and Diseases.
Heba Ewida, Harrison Benson, Syed Tareq, Mahmoud Salama Ahmed

ACS Pharmacol Transl Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of pyrazole-based analogs as CDK2 inhibitors with apoptotic-inducing activity: design, synthesis and molecular dynamics study.
Ghada M E Ali, Menna A Ewida, Amira M Elmetwali, Heba A Ewida, Riham F George

RSC Adv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reciprocal regulation of cardiac β-oxidation and pyruvate dehydrogenase by insulin.
Abdallah Elnwasany, Heba A Ewida, Ivan Menendez-Montes, Monika Mizerska, Xiaorong Fu

J Biol Chem· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered Lnc-EGFR, SNHG1, and LincRNA-Cox2 Profiles in Patients with Relapsing-Remitting Multiple Sclerosis: Impact on Disease Activity and Progression.
Mohamed S Attia, Heba A Ewida, Mohamed Aly Abdel Hafez, Shohda A El-Maraghy, Maha M El-Sawalhi

Diagnostics (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Pyruvate Dehydrogenase in the Heart as an Initiating Event in the Development of Diabetic Cardiomyopathy.
Abdallah Elnwasany, Heba A Ewida, Pamela A Szweda, Luke I Szweda

Antioxidants (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of miRNAs 9 and 342 expressions in sera as diagnostic and prognostic biomarkers for breast cancer.
Heba A Ewida, Marwa Shabayek, Mae Seleem

Breast Dis· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanomolar potency of imidazo[2,1-b]thiazole analogs as indoleamine 2,3-dioxygenase inhibitors.
Menna A Ewida, Heba A Ewida, Mahmoud S Ahmed, Heba Abdelrasheed Allam, Ramzia I ElBagary

Arch Pharm (Weinheim)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-Methyl-imidazo[2,1-b]thiazole derivatives as a new class of antifolates: Synthesis, in vitro/in vivo bio-evaluation and molecular modeling simulations.
Menna A Ewida, Heba A Ewida, Mahmoud S Ahmed, Heba Abdelrasheed Allam, Ramzia I ElBagary

Bioorg Chem· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating lncRNAs HIF1A-AS2 and LINLK-A: Role and Relation to Hypoxia-Inducible Factor-1α in Cerebral Stroke Patients.
Heba A Ewida, Rana K Zayed, Hebatallah A Darwish, Amira A Shaheen

Mol Neurobiol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNAs 342 and 450 together with NOX-4 activity and their association with coronary artery disease in diabetes.
Mae Seleem, Marwa Shabayek, Heba A Ewida

Diabetes Metab Res Rev· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, antitumor testing and molecular modeling study of some new 6-substituted amido, azo or thioureido-quinazolin-4(3H)-ones.
Mohamed A Sabry, Heba A Ewida, Ghada S Hassan, Mariam A Ghaly, Hussein I El-Subbagh

Bioorg Chem· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imidazo[2',1':2,3]thiazolo[4,5-d]pyridazinone as a new scaffold of DHFR inhibitors: Synthesis, biological evaluation and molecular modeling study.
Menna A Ewida, Dalal A Abou El Ella, Deena S Lasheen, Heba A Ewida, Yomna I El-Gazzar

Bioorg Chem· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and biological evaluation of novel amide and hydrazide based thioether analogs targeting Histone deacteylase (HDAC) enzymes.
Ayman B Farag, Heba A Ewida, Mahmoud Salama Ahmed

Eur J Med Chem· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thiazolo[4,5-d]pyridazine analogues as a new class of dihydrofolate reductase (DHFR) inhibitors: Synthesis, biological evaluation and molecular modeling study.
Menna A Ewida, Dalal A Abou El Ella, Deena S Lasheen, Heba A Ewida, Yomna I El-Gazzar

Bioorg Chem· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, biological evaluation and molecular modeling study of new (1,2,4-triazole or 1,3,4-thiadiazole)-methylthio-derivatives of quinazolin-4(3H)-one as DHFR inhibitors.
Yomna I El-Gazzar, Hanan H Georgey, Shahenda M El-Messery, Heba A Ewida, Ghada S Hassan, Menna A Ewida

Bioorg Chem· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis